Study Assessing Pain Relief After Replacement of the Knee

NCT05260008 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

112

Enrollment

INDUSTRY

Sponsor class

Stopped Based on positive data from the dose-ranging portion of the study, Sponsor decided as of May 28, 2024 not to move forward with the previously designed global ATX101-TKA-003 study.

Conditions

Acute Postoperative Pain

Interventions

DRUG: ATX-101
DRUG: ATX-101
DRUG: bupivacaine hydrochloride without epinephrine

Sponsor

Allay Therapeutics, Inc.